Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > 2,749000 TILRAY SHARES

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Oct 10, 2023 12:17pm

91 Views

Post# 35677199

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2,749000 TILRAY SHARES

Well done MDjbrown...this provision actually worked out for MPL, more than doubling the share payout to 2,750,000..it's amazing analysis made a major positive revision for Tilray the next day Oct,10th..today..this is a material change and will be the next PR sometime this week! Great investigative work, yet again this bullboard brings the goods before disclosure from the Corp. on another note..the biggest risk to MPL shareholders is a buyout at these levels...management needs to file a normal course issuer bid effective Jan 1, 2024 and begin divesting its stake in Tilray to purchase MPL shares for cancellation..IMO..

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”